IBO has made some minor changes to the separations market compared with last year’s forecast issue (see IBO 1/15/12). The overall market size and definition remain consistent, but how we account for a few categories has been updated. Perhaps the most obvious change is the addition of supercritical fluid chromatography (SFC), which was disaggregated from […]
Competitive Pressures Tough government and academic markets and, toward year end, slowing industrial markets, plus lagging global growth, made 2012 a year when instrument and lab product companies had to compete harder than usual in many markets. Many companies noted pricing pressure across product lines, particularly for sales to industrial markets. This effect also played […]
New York, NY 1/8/12—At the JPMorgan Global Healthcare Conference, Illumina announced the acquisition of Moleculo, a provider of technology enabling next-generation sequencing reads in excess of 10,000 bases. Illumina stated that it plans to commercialize the technology in the second quarter for phased genomes (indicating which parent an allele comes from) and for cancer research, […]
Santa Clara, CA 1/8/13—Affymetrix has announced preliminary 2012 revenues and a restructuring plan to improve profitability. The company estimates fourth-quarter revenues totaled $84 million, including $18 million in eBioscience sales. Year over year, revenue increased 1% excluding eBioscience, and eBioscience revenue grew 5%. Year-end revenues are estimated to be $295 million. The restructuring, which includes […]
US equity markets recorded strong gains in 2012 despite only modest economic growth. For the year, the Dow Jones Industrial Average, S&P 500 and NASDAQ climbed 7.3%, 13.4% and 15.9%, respectively. The markets shrugged off anxious headlines brought by the “fiscal cliff” crisis, European sovereign debt problems and slowing growth in emerging markets. Instead, investors […]
Company Announcements QIAGEN’s third-quarter sales grew 5.3%, 4% organically, to $304.3 million (see IBO 11/15/12), with acquisitions adding 6% and currency lowering sales by 5%. At constant exchange rates, Instruments, and Consumables and Related revenues increased 4% and 10% to account for 13% and 87% of sales, respectively. Molecular Diagnostics revenue rose 15% to account […]
Company Announcements In the third quarter, within Danaher’s Environmental segment, sales for existing water quality business grew low single digits (see IBO 10/31/12). Hach core revenue grew mid-single digits, as municipal spending for core lab and process instruments grew low single digits. Consumables and service represented 55% of water quality sales. Within the Life Sciences […]
Third-quarter 2012 Life Science Index sales grew 3.4%, 4.9% excluding currency, to $3,260 million. Operating profit improved 2.8% to $658 million. Based on continuing operations, operating margin slipped 20 basis points to 20.7% of sales. Fiscal fourth-quarter revenue for Becton Dickinson’s BD Biosciences segment, which consists of Cell Analysis and Advanced Bioprocessing products, fell 6.3%, […]
Equities were mostly higher in November despite concerns over the US budget deficit. Positive economic indicators included better-than-expected jobless claims and GDP growth, as well as rising housing prices and consumer confidence. On November 29, US third-quarter GDP growth was revised upward from 2.0% to 2.7%, primarily due to inventory investments. For the month, the […]
Major publicly held instrument and laboratory product businesses continued to weather a slow growth environment in the calendar-year third quarter. Revenues for the eight businesses whose quarterly results are detailed on pages 9–11 grew 2.0%, including approximately 4.2% organic growth (see table, page 9). This compares with reported sales growth of 3.1% last quarter, with […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
